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Abstract Technology Roadmap for Semiconductors (ITRS) clearly
identifies the integration of electrochemical and electro-
biological techniques as one of the system-level design
challenges that will be faced beyond 2009, when feature sizes
shrink below 50nm [5].
Microfluidics-based biochips are soon expected to revolutionize
clinical diagnosis, DNA sequencing, and other laboratory 
procedures involving molecular biology. Most microfluidic biochips
are based on the principle of continuous fluid flow and they rely on
permanently-etched microchannels, micropumps, and microvalves. 
We focus here on the automated design of “digital” droplet-based
microfluidic biochips. In contrast to continuous-flow systems, digital
microfluidics offers dynamic reconfigurability; groups of cells in a 
microfluidics array can be reconfigured to change their functionality 
during the concurrent execution of a set of bioassays. We present a
simulated annealing-based technique for module placement in such
biochips. The placement procedure not only addresses chip area, but 
it also considers fault tolerance, which allows a microfluidic module
to be relocated elsewhere in the system when a single cell is detected
to be faulty. Simulation results are presented for a case study 
involving the polymerase chain reaction.
Early research on CAD for digital microfluidics-based
biochips has been focused on device-level physical modeling
of single components [6]. While top-down system-level
design tools are now commonplace in IC design, no such
efforts have been reported for digital microfluidic chips. Here 
we propose a design methodology that attempts to apply
variants of classical module placement techniques to the
design of digital microfluidics-based biochips, and thus
reduce design time and human effort.
We envisage the following steps in the synthesis of
biochips. A behavioral model for a biochemical assay is first
generated from the labotorary protocol for that assay. Next,
architectural-level synthesis is used to generate a macroscopic
structure of the biochip; this structure is analogous to a
structural RTL model in electronic CAD. The macroscopic
model provides an assignment of assay functions to biochip
resources, as well as a mapping of assay functions to time-
steps, based in part on the dependencies between them.
Finally, geometry-level synthesis creates a physical 
representation at the geometrical level, i.e., the final layout of
the biochip consisting of the configuration of the microfluidic
array, locations of reservoirs and dispensing ports, and other
geometric details.
1.   Introduction 
Microfluidics-based biochips are receiving considerable
attention nowadays [1]. These composite microsystems,
which manipulate fluids at nanoliter-to-microliter scales, can
greatly simplify cumbersome laboratory procedures. Such
lab-on-a-chip devices are therefore expected to facilitate in-
vitro clinical diagnosis, DNA sequencing, and other common
procedures in molecular biology.
Most microfluidic biochips of today, consisting of
permanently-etched micropumps, microvalves, and
microchannels, are based on the principle of continuous fluid
flow [1]. A more promising approach is to manipulate liquids
as discrete microdroplets. This novel droplet-based technique
is referred to in the literature as “digital microfluidics” [2].
Each droplet can be controlled independently and each cell in 
the microfluidic array has the same structure. In contrast to 
the continuous-flow systems, digital microfluidics offers
dynamic reconfigurability as well as a scalable system
architecture [3]. Groups of cells can be dynamically
reconfigured to change their functionality during the
execution of a bioassay. Multiple assays can be concurrently
carried out on the microfluidic platform [4].
Many biochips are expected to be used for safety-critical
applications, e.g., patient health monitoring, neo-natal care,
and the monitoring of environmental toxins. Therefore, these
biochips must be designed to be fault-tolerant such that they
can continue to operate reliably in the presence of faults. One
approach to fault tolerance is to carefully include spare cells
in the array such that faulty cells can be bypassed without any
loss of functionality. The locations of the spare cells must be
determined by the physical design tool that maps modules to
sets of cells in the array. 
A key problem in the design of biochips is the placement
of microfluidic modules such as different types of mixers and
storage units. The ability to reconfigure the microfluidic array
during the execution of bioassays makes this placement
problem different from the traditional placement problem in
electronic design. Furthermore, the placement of the
microfluidic modules has a strong impact on the ease of
reconfigurability for fault tolerance. Thus, in addition to area 
(measured by the number of cells in the array), fault tolerance
is also a placement criterion. 
________________________________
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The complexity of digital microfluidics-based biochips is
expected to steadly increase due to the need for multiple and
concurrent assays on the chip. Time-to-market and fault 
tolerance are also expected to emerge as design
considerations. As a result, current full-custom design
techniques will not scale well for larger designs. There is a 
need to deliver the same level of CAD support to the biochip
designer that is now available to the semiconductor industry.
Moreover, it is expected that these microfluidic biochips will
be integrated with microelectronic components in next-
generation  system-on-chip designs. The 2003  International
In this paper, we focus on the problem of module
placement for digital microfluidics-based biochips with area
and fault tolerance as the placement criteria. An example of a
real-life biochemical procedure, i.e., polymerase chain 
Th
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reaction (PCR), is used to evaluate the proposed
methodology. Since the placement problem is known to be
NP-complete [7], a simulated annealing-based heuristic
approach is developed to solve the problem in a 
computationally efficient manner. Solutions for the placement
problem can provide the designer with guidelines on the size
of the array to be manufactured. If module placement is
carried out for a fabricated array, area minimization frees up
more cells for sample collection and preparation. We also
introduce a simple measure, referred to as the fault tolerance
index, to evaluate the fault tolerance capability of the
microfluidic biochip; this measure is incorporated into the
placement procedure. This procedure leads to small biochip 
area due to efficient utilization of dynamic reconfigurability,
as well as high fault tolerance due to the efficient use of spare 
cells.
Ground electrode Top plate
Bottom plate
Electrode gapControl electrodes
Hydrophobic
insulators
Droplet Fillerfluid
Control signals
I/O portI/O port
Cell
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   Figure 1: (a) Basic cell used in a digital microfluidics-based biochip;
(b) A 2-D array for digital microfluidics.
biochips is referred to as dynamic reconfigurability, which we 
exploit here for high fault tolerance. The configurations of the
microfluidic array are dynamically programmed into a 
microcontroller that controls the voltages of electrodes in the
array. In this sense, the microfluidic modules (e.g., mixers  or
storage  units) used during the operations can be viewed as
reconfigurable virtual devices.
3.   Related Prior Work The organization of the remainder of the paper is as
follows. In Section 2, we present an overview of digital
microfluidics-based biochips. Section 3 discusses related prior
work. In Section 4, we present a simulated annealing-based
heuristic for module placement in dynamically reconfigurable
biochips. Next, in Section 5, the reconfiguration technique is
studied in more details, and the fault tolerance index, is
defined. In Section 6, we incorporate the fault tolerance index
in the placement procedure; we then use PCR to evaluate the
enhanced placement procedure. Finally, conclusions are
drawn in Section 7. 
Physical design automation for integrated circuits,
especially module placement, is a mature topic [9]. Heuristics
such as simulated annealing are extensively used for
custom/macro cell placement; the placement problem is often 
formulated as 2-D rectangle packing [10]. Since these
techniques do not consider reconfigurability, they are not
directly applicable to programmable devices. Dynamically
Reconfigurable FPGAs (DRFPGAs) have received much 
attention recently [11]. The partial reconfiguration offered by
DRFPGAs is in many ways similar to the dynamic
reconfigurability provided by digital microfluidics-based
biochips. However, placement techniques reported thus far for
DRFPGAs have only targeted the minimization of chip area
[11]. Fault tolerance has not been considered in these
placement techniques. Moreover, the programmability of 
DRFPGAs is limited by the well-defined roles of interconnect
and logic blocks. Interconnect cannot be used for storing
information, and logic blocks cannot be used for routing. In
contrast, the digital microfluidics-based biochips offer
significantly more programmability. The cells in the
microfluidic array can be used for storage, functional
operations, as well as for transporting fluid droplets.
2.   Background 
The operation of digital microfluidics-based biochips is
based on the principle of electrowetting actuation.
Electrowetting refers to the modulation of the interfacial
tension between a conductive fluid and a solid electrode by
applying an electric field between them. The basic cell of a
digital microfluidics-based biochip is shown in Figure 1(a).
The droplet containing biochemical samples, and the filler
medium, such as silicone oil, are sandwiched between two 
parallel glass plates. The bottom plate contains a patterned
array of individually controllable electrodes, while the top
plate is coated with a ground electrode. A hydrophobic
dielectric insulator is added to the plates to decrease the
wettability of the surface and to add capacitance between the
droplet and the control electrode. By varying the electrical 
potential along a linear array of electrodes, nanoliter-volume
droplets can transport along this line of electrodes. The
velocity of the droplet (up to 20cm/s) can be controlled by
adjusting the control voltage (0~90V). Microdroplets can
therefore be moved freely to any location of a two-
dimensional array without the need for pumps and valves.
Figure 1(b) illustrates a fabricated microfluidic array [8].
As integrated circuits become denser, reliability emerges
as a major challenge. Historically, reliability has been 
addressed through robust manufacturing processes. However,
this approach does not address reliability issues associated
with system design. Although microelectromechanical
systems (MEMS) is a relatively young field compared to 
integrated circuits, reliability studies for MEMS have received
considerable attention [12]. However, due to the significant
differences in the actuation principles underlying between
digital microfluidics and MEMS, these reliability
enhancement techniques cannot be directly used for the
design of microfluidics-based biochips.Using a two-dimensional array, many common
microfluidic operations for biomedical assays can be
performed. For instance, the mixing operation is implemented
by routing two droplets to the same location and then turning
them around some pivot points. Note that these operations
can be performed anywhere on the array during the operation
of the biochip, whereas in continuous-flow systems they must
operate in a specific permanently-etched micromixer or
microchamber. This  property  of  digital  microfluidics-based
While system-level physical design automation tools are
now commonplace in integrated circuit design, no such efforts
have been reported for digital microfluidics-based biochips.
Some commercial computational fluidic dynamics (CFD)
tools, such as CFD-ACE+ from CFD Research Corporation
and FlumeCAD from Coventor, Inc. support 3-D simulation
of fluidic transport. A recent release of CoventorWare from
Coventor, Inc. includes microfluidic behavioral models to
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support system-level design. Unfortunately, this CAD tool is 
only able to deal with the continuous-flow systems, and it is 
therefore inadequate for the design of digital microfluidics-
based biochips.
Recently, a fault classification and a unified test 
methodology for digital microfluidics-based biochips have
been developed [13]. This cost-effective test methodology
facilitates on-line testing, which allows fault testing and
biochemical assays to run simultaneously on a microfluidics-
based biochip [14].
4.   Module Placement
Placement is one of the key physical design problems for
digital microfluidics-based biochips. Based on the results
obtained from architectural-level synthesis, i.e., a schedule of
bioassay operation, a set of microfluidic modules, and the
binding of bioassay operations to modules, placement
determines the locations of each module on the microfluidic
array in order to optimize some design metrics.  Since digital
microfluidics-based biochips enable dynamic reconfiguration
of the microfluidic array during run-time, they allow the
placement of different modules on the same location during
different time intervals. Thus, the placement of modules on
the microfluidic array can be modeled as a 3-D packing
problem. Each microfluidic module is represented by a 3-D
box, the base of which denotes the rectangular area of the
module and the height denotes the time-span of its operation.
The microfluidic biochip placement can now be viewed as the
problem of packing these boxes to minimize the total base
area, while avoiding overlaps.
    Figure 2: Reduction from 3_D placement to a modified 2-D placement.
Procedure PLACEMENT
/*Simulated Annealing-Based Module Placement */
1 P = Po;  /* Given initial placement */ 
2 T = T;  /* Given initial temperature*/
3 X = Xo;  /* Assign the annealing parameters */ 
4 while (“Stopping criterion” is not satisfied)
5 for i = 1: N  /* N is the number of iterations of the inner loop */ 
6 Pnew = generate (P); ∆C = cost_metric(Pnew)-cost_metric(P);
7 r = random(0, 1);  /* random(0, 1) is a function that returns a
8   pseudo-random number uniformly distributed on the interval [0, 1] */
9 if ∆C < 0 or r < exp(-∆C /T)  { P = Pnew ;}
10 end if
11 end for /* end of inner loop */ 
12 Tnew = Į×Told; /* updating (cooling) temperature */ 
13 end while /* end of annealing procedure */ 
14   output the optimal placement P.
Figure 3:  Simulated annealing-based placement procedure.
simulated annealing is that it explores the configuration space
of the optimization problem, while allowing hill-climbing
moves, i.e., acceptance of new configurations that increase
the cost.  In this  paper,  we develop a  simulated annealing-
based algorithm to solve the placement problem for the digital
microfluidics-based biochips. Instead of using a complicated
problem-encoding scheme as in [15], our method directly
applies the annealing procedure to the actual physical
coordinates, sizes, and orientations of microfluidic modules.
Since the direct approach cannot guarantee that each new 
placement is a feasible solution without any forbidden overlap,
penalty for such forbidden overlaps is included in the cost
function. The algorithm seeks to optimize the design metric
while driving the overlap penalty to zero. The pseudocode for
this heuristic approach is shown in Figure 3. Some important
details of the algorithm are as follows.
Since placement follows architectural-level synthesis in
the proposed synthesis flow, the starting times for each 
operation corresponding to a module, i.e., their positions in 
the time axis, are pre-determined. Therefore, the 3-D packing
problem can be reduced to a modified 2-D placement problem.
The horizontal cuts with the 3-D boxes correspond to the
configurations of the microfluidic array at different point in
time. For example, in Figure 3, the cut t = t1 corresponds to a 
2-D placement shown in Figure 2(b), and the cut t = t2
corresponds to another configuration in Figure 2(c). The
configurations of the microfluidic array during different time
intervals can be combined together to form a modified 2-D
placement shown in Figure 2(c). Note that the base of the 3-D
box representing module i should be placed on the cutting
plane t = Si, where Si is the starting time of module i’s
operation determined by architectural-level synthesis.  The
modules can arbitrarily slide on these fixed cutting planes
while avoiding overlap. Thus, instead of a 3-D packing
problem, we only need to consider a modified 2-D placement
consisting of several 2-D configurations in different time
spans.
a) Initial placement: It has been reported in the literature that
the initial configuration has little impact on the final outcome
of simulated annealing-based optimization [10]. Therefore,
we apply a simple constructive approach to formulate the
initial placement, as shown in Figure 4(a). In addition, during
the annealing process, the modules are prevented from being
placed outside the boundaries of the core area, as defined by
Figure 4(a).
The module placement problem for electronic design is
known to be NP-complete [7]. The microfluidic placement
problem can also be shown by the method of restriction to be
NP-complete. Consequently, heuristics are needed to solve
the placement problem in a computationally efficient manner.
Simulated annealing is a well-studied combinatorial
optimization method, and it has been extensively used for
traditional module placement problems [10]. An advantage of
b) Generation function: New placements can be generated in 
several ways: (i) A single microfluidic module is randomly
selected to be moved to a randomly-chosen location; (ii) A 
single module is randomly displaced to a new location and the
orientation of this module is changed; (iii) A pair of modules
are randomly selected for interchange;  (iv) A pair of modules
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Figure 4: (a) Initial placement; (b) Example of partial reconfiguration.
are interchanged in which at least one module has its
orientation changed. During the annealing process, we assign
the probability p  to  the  single-module  displacement and 
1íp to the two-module interchange. An effective ratio of
p/(1íp) is determined experimentally.
c) Controlling window for single-module displacement: The
displacement of a single module by a large distance leads to
the large increase in the cost metric (ǻC > 0). At low
temperatures during the annealing process, only the new
generations with ǻC  0 have a reasonable chance of being
accepted. This increases the probability that the displacements
over large distances are rejected. We apply a controlling 
window to discourage long-distance displacements at low
temperatures. As the temperature approaches zero, the span of
the controlling window reaches its minimum value; this
condition is used as the stopping criterion for simulated
annealing.
d) Annealing scheme: Most annealing parameters are 
experimentally determined. These include the following: (i) 
The temperature is modulated as Tnew = Į×Told, where Į = 0.9;
(ii) The number of iterations of the inner loop for a given
value of T is determined using the relationship N = Na × Nm,
where Na = 400 and Nm is the number of the modules; (ii)
The initial temperature T is chosen to ensure that almost
every new placement can be accepted, here T= 10000.
e) Cost metrics: Cost metrics are used to mathematically
represent the optimization goals of the placement problem.
We consider the area of the array and the degree of fault
tolerance as cost metrics.
5.   Fault Tolerance and Reconfiguration
In this section, we investigate dynamic and partial
reconfiguration to avoid a faulty cell in the microfluidic array. 
Based on this reconfiguration technique, a simple numerical
measure, termed fault tolerance index, is defined to estimate
the fault tolerance capability of the biochip. We also present
an efficient algorithm to determine the fault tolerance index of
a biochip configuration based on the notion of maximal-
empty rectangles.
5.1  Partial Reconfiguration
A digital microfluidics-based biochip can be viewed as a 
dynamically reconfigurable system. If a cell becomes faulty
during the operation of the biochip, detected using the
technique described in [13], the microfluidic module
containing this cell can easily be relocated to another part of 
the microfluidic array by changing the control voltages
applied to the corresponding electrodes. An example of partial
reconfiguration is shown in Figure 4(b). Fault-free unused
cells in the array are utilized to accommodate the faulty
module. Hence, the configuration of the microfluidic array,
i.e., the placement of the microfluidic modules, influences the
fault tolerance capability of the biochip. Moreover, since
partial reconfiguration only targets the module containing the
faulty cell and leaves other aspects of the microfluidic
configuration unchanged, a fast heuristic algorithm can be
used to find a new location for this module. Therefore, partial
reconfiguration is suitable for dynamic on-line
reconfiguration during field operation of the microfluidic
biochip.
5.2  Fault Tolerance Index
In order to facilitate partial reconfiguration and
incorporate fault tolerance in the simulated annealing-based
placement procedure, we need to evaluate the fault tolerance
capability of the microfluidic biochip.
We consider the reconfiguration problem for a single
failing cell in the microfluidic array. The single fault
assumption is valid when testing and reconfiguration are
carried out frequently. We also assume that every cell has the 
same failure probability. Since microfluidic biochips have not
yet been manufactured in large numbers, failure data or
statistical models are not readily available, and the
assumption of uniform failure probability is reasonable. The
failure model can be easily updated when statistical failure
data becomes available.
We use a 2-D coordinate system to refer to the cells in the
microfluidic array. The bottom-left cell is referred to as (1, 1)
and the top-right cell in an m×n array is referred to as (m, n).
For an m×n microfluidic array, assume that an arbitrary cell (i,
j) is faulty. If this cell is contained in a module for a given
microfluidic configuration C, we attempt to apply partial
reconfiguration to relocate this module to avoid the faulty cell.
If this reconfiguration succeeds, i.e., we find an adequate
number of contiguous cells to accommodate this module, or
cell (i, j) is not used by any module, we deem this cell to be
C-covered for this configuration. Otherwise, cell (i, j) is not
C-covered. For an array with k C-covered cells, we define the
fault tolerance index (FTI) as follows:  FTI = k/(m×n).
Noted that FTI lies between 0 and 1. It increases if there
are more C-covered cells in the array. If FTI is 1, it implies
that when any single cell in the array is faulty, this
microfluidic configuration can be used by applying partial
reconfiguration to bypass the faulty cell. On the other hand, if 
FTI is 0, the biochip cannot be reconfigured if any arbitrary
cell becomes faulty. This is the worst case that needs to be
avoided.
In order to determine if a cell is C-covered for
configuration C, we use an efficient procedure based on the
notion of maximal-empty rectangles. The details of this
procedure are described below.
5.3  Fast algorithm to determine FTI
Our goal is to find maximal-empty rectangles in the
microfluidic array, and then check if these rectangles can
accommodate the faulty module. A maximal empty rectangle
is defined as an empty rectangle (a set of unused cells) that
cannot be completely covered by any other empty rectangles.
If a maximal-empty rectangle can accommodate the faulty
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module, this module can be relocated to the empty rectangle
to avoid the faulty cell. If no such maximal-empty rectangle
exists, partial reconfiguration is deemed to have failed. We
then conclude that the corresponding faulty is not C-covered.
Table 1: Resource binding in PCR.
Operation Hardware* Module Mixing time
M1 2x2 electrode array 4x4 cells 10s
M2 4-electrode linear array 3x6 cells 5s
M3 2x3 electrode array 4x5 cells 6s
M4 4-electrode linear array 3x6 cells 5s
M5 4-electrode linear array 3x6 cells 5s
M6 2x2 electrode array 4x4 cells 10s
M7 2x4 electrode array 4x6 cells 3s
An encoding method is first used to facilitate the
implementation of this algorithm. If a module contains a
faulty cell, this module is temporarily removed from the
placement. Next the configuration of the microfluidic array is 
modeled by a matrix consisting of 0s and 1s. The faulty cell
and all cells contained in the currently operational modules
are represented by 1s; all unused cells are represented by 0s.
*: Electrode pitch: 1.5 mm; Gap height: 600 µm
In order to find all maximal-empty rectangles rapidly, a
data structure, referred to as the staircase [16], is employed in
the algorithm. A staircase(x, y) is defined as the collection of
all overlapping empty rectangles with (x, y) as their bottom-
right corner.
The data structure staircase(x, y) help to determine all
maximal-empty rectangles that lie entirely within the
staircase(x, y) and whose bottom-right corner is (x, y). The 
algorithm traverses the matrix left-to-right and top-to-bottom,
creating a staircase for every cell in the matrix. Next, based on
the knowledge of staircases, all maximal-empty rectangles are 
determined. The details underlying the construction of 
staircases and the generation of the maximal-empty rectangles
from staircases are described in [16].
Figure 6: Schedule highlighting the usage of microfluidic modules.
6.1  Enhanced module placement algorithm
We use a simple greedy algorithm as a baseline for
assessing the quality of the proposed placement method.
Modules are first sorted in the descending order based on their
areas. In each step, the module with the largest area among
the unplaced ones is selected and placed at an available
bottom-left corner of the array. The total area of the
placement generated is 189mm2, i.e., it consists of 84 cells,
where the pitch of each cell is 1.5mm.
6.   Experimental Evaluation: PCR 
Polymerase chain reaction (PCR) is one of the most
common techniques for DNA analysis [17]. It is used for
rapid enzymatic amplification of specific DNA fragments.
PCR can amplify genomic DNA exponentially using
temperature cycles. Recently, the feasibility of performing
droplet-based PCR on digital microfluidics-based biochips
has been successfully demonstrated [2]. In this section, we 
use the mixing stage of PCR as an example to evaluate the 
simulated annealing-based placement algorithm that facilitates
fault tolerance. Its assay protocol can be modeled by a 
sequencing graph [17], as shown in Figure 5. 
Next we apply the placement procedure of Section 4 to
this example. First, we consider the minimization of the array
area as the only cost metric. The placement generated by the 
simulated annealing procedure is shown in Figure 7. Its total
area is 141.75mm2 (63 cells), which is 25% less compared to 
the baseline. The computation takes 5 minutes of CPU time
on a 1.0 GHz Pentium-III PC with 256 MB of RAM. Note
that some microfluidic modules, e.g., Modules 1 and 3, can
use the same cells (via dynamic reconfiguration) when their
time-spans do not overlap.
Figure 7: Placement obtained from the simulated annealing-based
procedure (7x9=63 cells).
Figure 5: Sequencing graph for the mixing stage of PCR.
Due to the efficient utilization of dynamic
reconfigurability, the algorithm leads to a highly compact
placement. However, the placement with the minimum array
area does not provide adequate fault tolerance. We determine
the FTI of the placement shown in Figure 7 using the fast 
algorithm described in Section 5.3. (The calculation of FTI
takes only 1.7 seconds of CPU time.) The FTI of this design is 
only 0.1270, which implies that only 8 cells in this 7×9 array
are C-covered. A microfluidics-based biochip with such a low
degree of fault tolerance is not suitable for critical DNA 
analysis.
Based on this graph model, architectural-level synthesis
can be used to carry out both resource binding and scheduling.
Let the resource binding be as shown in Table 1. Note that the
module generated here has a segregation region wrapped
around the functional region, which not only isolates the
functional region from its neighbors but also provides a 
communication path for droplet movement. The data for the
operation times associated with the different modules are
obtained from real-life experiments [18]. A schedule for the
functional operations and module usage is shown in Figure 6.
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The goal of the enhanced placement algorithm is to 
maximize FTI, while keeping the total biochip area small. FTI 
and area are conflicting criteria, because high FTI often
requires a larger biochip area. In our multi-objective
placement problem, a solution is a 2-tuple (area, FTI)
resulting from a feasible placement of microfluidic modules.
Table 2: Solutions for different value of β.
β 10 20 30 40 50 60
Area (mm2) 141.75 157.5 173.25 189.0 204.75 222.75
FTI 0.2857 0.7143 0.8052 0.8571 0.9780 1.0
7.   Conclusions 
We have presented a simulated annealing-based technique
for module placement in microfluidic biochips. The
placement criteria include chip area as well as fault tolerance;
the latter allows a microfluidic module to be relocated
elsewhere in the system when a single cell is detected to be 
faulty. The placement problem accounts for dynamic
reconfigurability of droplet-based microfluidics, whereby
groups of cells can be reconfigured to change their 
functionality during the concurrent execution of a set of
bioassays. We have presented simulation results for a case
study involving the polymerase chain reaction. This work is
expected to facilitate the automated design of biochips,
especially since their complexity is expected to grow steadily
as they are increasingly used for clinical diagnosis, DNA
sequencing, and other laboratory procedures involving
molecular biology.
Weighting is a commonly used method for multi-objective
optimization. A weight is assigned to each objective
according to its relative importance. Next, the different
objectives are combined into a single objective using a 
weighted sum. The solution with the lowest weighted sum is
selected. In our problem, weights α and β are assigned to the
criteria of area and FTI, respectively. We set α to 1 and 
adjusted β according to the degree of importance of fault
tolerance. The solution with the lowest value of the metric
(α×area−β×fault-tolerance number) was considered to be an
acceptable solution.
We used a two-stage simulated annealing-based algorithm.
In the first stage, a fault-oblivious simulated annealing-based
algorithm is used to obtain a placement with the smallest area.
Starting from this intermediate configuration, the second stage
uses low-temperature simulated annealing (LTSA) to refine
the placement in order to enhance fault tolerance. The FTI
measure is included in the cost function, while the total area is
kept as small as possible. In addition, during LTSA, only 
single module displacement is performed.
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